临床招募-肺癌综合整理
本帖最后由 小曲 于 2023-5-9 15:16 编辑治疗方式治疗史靶点方案设计项目名称项目链接
靶向术后EGFR敏感突变双臂且有安慰剂伏美替尼（EGFR突变）https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=111904&fromuid=79742
术后ALK双臂，对比安慰剂临床招募|恩沙替尼招募非小细胞肺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=112116&fromuid=79742
一线EGFR 20ins单臂临床招募|FWD1509 MsOH招募EGFR突变晚期NSCLC患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=111670&fromuid=79742
EGFR 20ins双臂，对比化疗DZD9008招募20ins非小细胞肺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=113989&fromuid=79742
ALK双臂，对比克唑替尼临床招募|XZP-3621招募ALK阳性晚期非小细胞肺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=111660&fromuid=79742
ALK/ROS1双臂，对比？Entrectinib胶囊招募非小细胞肺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=114129&fromuid=79742
MET 14跳突单臂INC280招募非小细胞肺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=114102&fromuid=79742
一线或二线ALK单臂临床招募|CT-707招募非小细胞肺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=113291&fromuid=79742
RET单臂临床招募|A400招募非小细胞肺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=113290&fromuid=79742
KRAS G12C双臂，对比？JDQ443招募非小细胞肺癌患者（KRAS G12C）https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=114131&fromuid=79742
二线及以后EGFR C797S突变和/或ALK阳性单臂临床招募|DAJH-1050766招募经EGFR TKI治疗失败伴C797S突变的晚期非小细胞肺癌https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=111898&fromuid=79742
EGFR突变单臂临床招募|PLB1004招募非小细胞患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=111668&fromuid=79742
EGFR 四代（需EGFR C797S）单臂临床招募|H002招募经EGFR-TKI治疗失败伴C797S突变的晚期非小https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=111899&fromuid=79742
EGFR 20ins单臂临床招募|BEBT-109胶囊招募非小细胞肺a癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=112173&fromuid=79742
EGFR 20ins及其他罕见突变；
HER2 20ins单臂临床招募|HTMC0503招募EGFR突变的晚期非小细胞肺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=111676&fromuid=79742
ALK单臂临床招募 | CT-3505胶囊招募ALK阳性非小细胞肺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=112477&fromuid=79742
MET 14跳突/扩增单臂临床招募|谷美替尼招募MET异常的晚期非小细胞肺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=111677&fromuid=79742
ROS1融合单臂临床招募|洛拉替尼招募ROS1阳性患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=111905&fromuid=79742
HER2 20ins？双臂，对比化疗临床招募|吡咯替尼招募HER2突变晚期非小细胞肺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=111727&fromuid=79742
HER2 ADC类药单臂临床招募|SHR-A1811招募HER2过表达扩增或突变的晚期NSCLC患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=111743&fromuid=79742
HER2 ADC类药单臂临床招募|FS-1502招募HER2异常的非小细胞肺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=111909&fromuid=79742
HER2扩增单臂临床招募|ST-1703片招募肺癌等实体瘤患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=113389&fromuid=79742
KRSA G12C单臂临床招募|D-1553招募KRAS G12C突变的晚期或转移性实体瘤https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=111656&fromuid=79742
KRAS G12C单臂临床招募|HJ891招募肺癌，胰腺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=113402&fromuid=79742
KRAS G12C双臂，对比？RO7435846片招募非小细胞肺癌患者（KRAS G12C）https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=114124&fromuid=79742
KRAS G12C双臂，对比化疗临床招募|MRTX849招募KRAS G12C突变的晚期非小细胞肺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=111908&fromuid=79742
FGFR突变单臂临床招募|SC0011治疗FGF/FGFR异常的晚期胃癌/治疗失败的晚期非小细胞肺癌https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=111741&fromuid=79742
免疫术后PD-1/PD-L1单臂临床招募|JS001招募可手术IIIA期非小细胞肺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=112049&fromuid=79742
一线双臂，对比单K临床招募|TQB2450注射液联合盐酸安罗替尼胶囊对比帕博利珠...https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=112199&fromuid=79742
双臂，对比K临床招募|BGB-A1217招募非小细胞肺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=113275&fromuid=79742
双臂，对比？阿替利珠单抗招募晚期初诊非小细胞肺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=114097&fromuid=79742
双臂，对比仅化疗临床招募|BCD-100招募非小细胞肺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=112112&fromuid=79742
二三线双臂，对比化疗临床招募|替雷利珠单抗联合Sitravatinib招募非小细胞肺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=112055&fromuid=79742
一线抗TIGIT/PD-1单臂MK-7684A注射液（非小细胞肺癌）https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=112201&fromuid=79742
一线及以后CAR-NK单臂临床招募|IBR-854注射液招募非小细胞肺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=113319&fromuid=79742
一线及以后EGFR抗体/IL-10单臂临床招募|DF203注射液招募肺癌等实体瘤患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=113382&fromuid=79742
很清楚
页:
[1]